Video Experimental Relacionado
Updated: Apr 13, 2026
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
11.7K
Conceptos actuales en la farmacoterapia dirigida a la enfermedad pulmonar obstructiva crónica: progreso hacia un
Prescott G Woodruff1, Alvar Agusti2, Nicolas Roche3
1Division of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine and Cardiovascular Research Institute, University of California, San Francisco, CA, USA.
Lancet (London, England)
|May 7, 2015
Resumen
La comprensión de la enfermedad pulmonar obstructiva crónica (EPOC) requiere la identificación de subgrupos de pacientes. Dirigirse a endotipos específicos con biomarcadores avanzará en el tratamiento personalizado de la EPOC y el desarrollo de fármacos.
Área de la Ciencia:
- Medicina Pulmonar La medicina pulmonar es el tratamiento de las enfermedades pulmonares.
- Investigación traslacional Investigación traslacional.
- El descubrimiento de biomarcadores.
Sus antecedentes:
- La enfermedad pulmonar obstructiva crónica (EPOC) es un trastorno respiratorio complejo y heterogéneo con un impacto significativo en la salud y la economía mundial.
- Las directrices actuales de tratamiento clasifican el manejo de la EPOC en la mejora de los síntomas y la reducción del riesgo, avanzando hacia la medicina individualizada.
- Los fenotipos clínicos, aunque útiles, pueden superponerse y pueden derivarse de diversos mecanismos biológicos, lo que requiere una comprensión más profunda.
Objetivo del estudio:
- Explorar el concepto de endotipos en la EPOC como subtipos fisiopatológicos distintos.
- Para resaltar la importancia de identificar biomarcadores específicos para estos endotipos.
- Para discutir cómo los enfoques basados en el endotipo pueden refinar la práctica clínica y el desarrollo de fármacos para la EPOC.
Principales métodos:
- Revisión de las directrices actuales de EPOC y las estrategias de tratamiento.
- Discusión de las limitaciones de los fenotipos clínicos en la orientación de la medicina personalizada.
- Exploración de conceptos emergentes como endotipos y análisis de redes en la complejidad de la enfermedad.
Principales resultados:
- Los fenotipos clínicos pueden no capturar completamente la heterogeneidad biológica de la EPOC.
- Dirigirse a endotipos específicos con biomarcadores validados es prometedor para terapias más efectivas.
- Los fármacos emergentes dirigidos a vías inflamatorias específicas requieren la identificación de endotipos y biomarcadores para el éxito de los ensayos.
Conclusiones:
- El tratamiento personalizado para la EPOC requiere un cambio hacia la comprensión y la orientación de los endotipos subyacentes.
- Los biomarcadores son cruciales para identificar los endotipos y permitir la medicina de precisión en la EPOC.
- El análisis de la red y la investigación adicional son vitales para reclasificar enfermedades complejas como la EPOC y desarrollar nuevos tratamientos.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.4K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.4K
01:26COPD: Management Using Bronchodilators and Corticosteroids
1.2K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K
01:24Chronic Obstructive Pulmonary Disease
3.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.3K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.5K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.2K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.2K
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.6K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.6K